Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : NT-Z001
Therapeutic Area : Neurology
Study Phase : IND Enabling
Recipient : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration
Charles River and Navega Announce Gene Therapy Manufacturing Collaboration
Details : The collaboration supports Navega's NT-Z001 for chronic pain in rare diseases like small fiber neuropathy and primary erythromelalgia.
Brand Name : NT-Z001
Molecule Type : Cell and Gene therapy
Upfront Cash : Undisclosed
March 14, 2024
Lead Product(s) : NT-Z001
Therapeutic Area : Neurology
Highest Development Status : IND Enabling
Recipient : Charles River Laboratories, Inc
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?